Claudia Mascia
Overview
Explore the profile of Claudia Mascia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vita S, Mascia C, Kertusha B, Marocco R, Sauzullo I, Mengoni F, et al.
J Infect Dev Ctries
. 2024 Jan;
17(12):1829-1833.
PMID: 38252716
Introduction: Skeletal tuberculosis (TB) accounts for about 10 to 35% of extrapulmonary cases and the knee is the most frequent site after the spine and hip. The diagnosis is difficult...
2.
Caraffa E, Mascia C, Ciardi M, Lichtner M, Ajassa C, Borgo C, et al.
J Infect Chemother
. 2023 Oct;
30(3):201-207.
PMID: 37820949
Introduction: Since early January 2017, a new measles outbreak in Italy has been observed. The aim of the study was to compare features between adults and children measles cases and...
3.
Vita S, Zuccala P, Savinelli S, Mascia C, Rossi R, Schiavone F, et al.
J Immunol Res
. 2020 Apr;
2020:2781350.
PMID: 32258171
Chronic hepatitis C virus infection leads to the activation of innate immunity, a key component in HCV fibrosis. In the past, the use of IFN-based treatment regimens did not permit...
4.
Sauzullo I, Mengoni F, Mascia C, Pavone P, Savelloni G, Massetti A, et al.
Med Microbiol Immunol
. 2019 Jan;
208(2):171-183.
PMID: 30623240
The new QuantiFERON-TB Gold Plus employs modified peptides optimized to elicit an IFNγ response from CD8 cytotoxic T lymphocytes in addition to CD4 T cells. With a view to improve...
5.
Iannetta M, Savinelli S, Rossi R, Mascia C, Marocco R, Vita S, et al.
Immunobiology
. 2018 Dec;
224(2):231-241.
PMID: 30522891
HIV infection is characterized by a state of chronic activation of the immune system, which is not completely reversed by antiretroviral treatment (ART). The aim of this study was to...
6.
Mascia C, Pozzetto I, Kertusha B, Marocco R, Borgo C, Tieghi T, et al.
PLoS One
. 2018 May;
13(5):e0198174.
PMID: 29795672
Background And Aims: Measles is an infectious disease that represents a serious public health problem worldwide, being associated with increased susceptibility to secondary infections, especially in the respiratory and gastrointestinal...
7.
Pavone P, Alfieri G, Corano-Scheri G, Pinacchio C, Fard S, Mascia C, et al.
Clin Res Hepatol Gastroenterol
. 2018 May;
42(3):e45-e48.
PMID: 29735250
No abstract available.
8.
Mascia C, Vita S, Zuccala P, Marocco R, Tieghi T, Savinelli S, et al.
PLoS One
. 2017 Jun;
12(6):e0179400.
PMID: 28636655
Background And Aims: Increased levels of chemokine interferon-gamma (IFN-γ)-inducible protein-10 (CXCL10), soluble CD163 (sCD163) and soluble CD14 (sCD14) have been reported in HCV infection. The aim of this study was...
9.
Mascia C, Lichtner M, Zuccala P, Vita S, Tieghi T, Marocco R, et al.
Clin Res Hepatol Gastroenterol
. 2017 Jun;
41(6):644-655.
PMID: 28578937
Background And Objective: Interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble (s) CD163 and sCD14 play an important role in the pathogenesis of HCV and HIV infection and are involved in inflammation and...
10.
Vita S, Ajassa C, Caraffa E, Lichtner M, Mascia C, Mengoni F, et al.
BMC Res Notes
. 2017 Mar;
10(1):123.
PMID: 28288691
Background: Pediatric tuberculous meningitis is a highly morbid, often fatal disease. Its prompt diagnosis and treatment saves lives, in fact delays in the initiation of therapy have been associated with...